![]() |
市場調查報告書
商品編碼
2049596
內視鏡設備市場規模、佔有率、趨勢和預測:按類型、應用、最終用途和地區分類,2026-2034年Endoscopy Devices Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2026-2034 |
||||||
2025年全球內視鏡設備市場規模為528億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以5.46%的複合年成長率成長,到2034年達到869億美元。目前,北美在內視鏡設備市場佔有主導地位,預計2025年將佔超過38.6%的市場。該市場正經歷穩定成長,這主要得益於微創手術在各個醫療領域的日益普及、需要頻繁進行內視鏡檢查以早期發現的胃腸道疾病和癌症發病率的上升,以及技術的不斷進步。
全球內視鏡設備市場的成長主要受微創外科技術的進步、胃腸道疾病和慢性病的盛行率上升以及人口老化對診斷和治療的需求等因素所驅動。此外,人們對疾病早期檢測意識的提高以及高解析度成像系統和機器人輔助內視鏡等技術創新也進一步推動了市場成長。 2024年12月10日,美國食品藥物管理局(FDA)授予EndoQuest Robotics公司一項臨床實驗醫療設備豁免(IDE)許可,用於開展一項名為PARADIGM的領先臨床試驗,該試驗旨在評估該公司新型腔內手術(ELS)系統在機器人輔助內視鏡黏膜下剝離術(ESD)治療結直腸病變中的安全性和性能。這項多中心試驗將核准來自美國頂尖醫療機構的50名患者,旨在透過靈活的機器人技術革新微創手術,實現無疤痕手術。新興經濟體醫療成本的上升和醫療設施可近性的改善也推動了對內視鏡設備的需求。此外,門診治療的普及性和對經濟實惠的治療方案的偏好也是推動市場成長的因素。
美國作為重要的區域市場脫穎而出,其主要驅動力是肥胖症、大腸癌和其他文明病的日益普遍,這些疾病需要先進的診斷工具。有利的報銷政策和完善的醫療保健基礎設施支持內視鏡技術的廣泛應用。此外,老年人口的不斷成長,以及易患慢性疾病需要頻繁診斷和治療性介入,進一步推動了市場需求。同時,領先企業持續的研發投入正在推出創新技術,例如一次性內視鏡和人工智慧輔助影像診斷。 2025年1月25日,波士頓科學公司在美國有限範圍內推出了VersaVue,這是一款獲得FDA已通過核准的一次性軟性膀胱鏡,旨在改善泌尿系統疾病的診斷和治療。這款小巧便攜的設備具有高清成像功能,採用一次性無菌設計,最大限度地降低了感染風險,無需像可重複使用的內視鏡那樣進行再處理和維護。波士頓科學公司將在美國獨家銷售VersaVue,目標是改善臨床工作流程和患者照護。同時,人們對疾病早期檢測的興趣日益濃厚,以及向以價值為基礎的醫療保健模式的轉變,也刺激了全美對內視鏡設備的需求。
內視鏡設備的技術進步
全球內視鏡設備市場佔有率的成長主要受外科手術量增加和器官特異性癌症發生率上升的推動。根據世界衛生組織(WHO)統計,大腸直腸癌是全球第三大常見癌症,每年新增病例超過190萬例,這推動了對高解析度影像和先進軟式內視鏡的需求。高解析度影像、微創手術技術以及可視性增強的軟式內視鏡等技術進步正在革新診斷和治療領域。這些進步使得各種疾病的診斷和治療更加精準,對身體負擔更小,從而縮短了患者的康復時間並降低了醫療成本。此外,人工智慧(AI)和機器學習在內鏡檢查中的應用提高了疾病識別的準確性和檢查效率。因此,醫生對先進內視鏡技術的接受度不斷提高,推動了內視鏡設備市場的成長,並擴大了對先進內視鏡系統持續研發的需求。
胃腸道疾病和癌症發生率不斷上升
胃腸道疾病和癌症的日益普及是推動內視鏡設備需求成長的主要因素。包括大腸直腸癌、消化道出血和發炎性腸道疾病在內的多種內視鏡適應症的患者群體,均可被視為具有代表性的臨床目標族群。 2020年,國際癌症研究機構(IARC)報告稱,全球新增癌症病例1,930萬例。其中許多癌症為消化器官系統癌症,僅大腸癌每年就導致超過93.5萬人死亡。內視鏡技術早期診斷已顯著提高了消化器官系統的存活率,存活率提高了40%。除了技術進步之外,早期診斷能夠幫助患者儘早接受治療,這對獲得良好的治療效果至關重要,從而推動了內視鏡應用的擴展。此外,老年人口的成長(老年人更容易罹患這些疾病)也進一步促進了市場成長。此外,人們健康意識的提高以及內視鏡檢查在常規患者監測中日益重要,也促使內視鏡設備的整體需求持續成長。這是因為內視鏡檢查在應對全球日益嚴重的胃腸道癌症和其他癌症方面發揮著至關重要的作用。
拓展內視鏡檢查在各醫學領域的應用
內視鏡技術在各個醫學領域的廣泛應用正在推動全球內視鏡設備市場規模的成長。除了胃腸病學之外,內視鏡技術在泌尿系統、婦科、呼吸系統醫療設備和整形外科等眾多臨床專科中也至關重要。根據美國肺臟協會統計,支氣管鏡檢查在肺部疾病(包括每年影響220萬人的肺癌)的診斷中應用日益廣泛。這些多樣化的應用推動了針對特定臨床需求的專用內視鏡儀器的研發。此外,內視鏡技術在診斷和治療人體各系統疾病方面的應用不斷擴展,也促進了市場需求的成長。例如,腹腔鏡婦科手術治療子宮內膜異位症和微創泌尿系統手術治療腎結石等。內視鏡技術的不斷應用不僅推動了市場成長,同時也積極促進了針對特定醫學領域的新型專用內視鏡儀器的研發。
The global endoscopy devices market size was valued at USD 52.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 86.9 Billion by 2034, exhibiting a CAGR of 5.46% during 2026-2034. North America currently dominates the endoscopy devices market share , holding a significant market share of over 38.6% in 2025. The market is experiencing steady growth driven by the growing adoption of minimally invasive surgeries across various medical fields, the rising prevalence of gastrointestinal diseases and cancer necessitating frequent endoscopic procedures for early detection, and continual technological advancements.
The global endoscopy devices market growth is primarily driven by advancements in minimally invasive surgical techniques, growing prevalence of gastrointestinal and chronic diseases, and an aging population requiring diagnostic and therapeutic procedures. Along with this, rising awareness of early disease detection and technological innovations, such as high-definition imaging systems and robot-assisted endoscopy, further propels market growth. On 10th December 2024, The FDA granted EndoQuest Robotics its Investigational Device Exemption for the company's pivotal PARADIGM clinical study to assess the safety and performance of its novel Endoluminal Surgical (ELS) System in robotic endoscopic submucosal dissection (ESD) for colorectal lesion removal. The multicenter trial will enroll 50 patients across top U.S. healthcare institutions in an effort to transform minimally invasive surgery through flexible robotic technology, allowing procedures without leaving scars. Rising healthcare expenditures and improved access to medical facilities in emerging economies are driving demand for endoscopy devices. Additionally, the shift to outpatient settings and the preference for cost-effective procedures further support market growth.
The United States stands out as a key regional market, primarily driven by the increasing prevalence of obesity, colorectal cancer, and other lifestyle-related disorders that require advanced diagnostic tools. Favorable reimbursement policies and strong healthcare infrastructure support widespread adoption of endoscopic procedures. In addition, the rising geriatric population, prone to chronic conditions requiring frequent diagnostic and therapeutic interventions, further fuels demand. Furthermore, ongoing research and development efforts by key players are introducing innovative technologies such as single-use endoscopes and AI-assisted imaging. On 25th January 2025, Boston Scientific initiated a limited market launch of its FDA-cleared VersaVue single-use flexible cystoscope, intended to improve diagnostics and treatments for urinary tract diseases. The compact, portable instrument features high-definition imaging, a single-use sterile design to minimize the risk of infection, and no requirement for reprocessing and maintenance of reusable scopes. Boston Scientific will exclusively distribute VersaVue in the United States, targeting improvements in clinical workflows and patient care. Concurrently, the growing focus on early disease detection and the shift toward value-based care models also stimulate endoscopy devices market demand across the United States.
Technological Advancements in Endoscopic Equipment
The global endoscopy devices market share is driven by the increase in surgical procedures and organ-specific cancers. According to the World Health Organization (WHO), colorectal cancer is the third most common cancer globally, with over 1.9 million cases annually, driving demand for high-definition imaging and advanced flexible endoscopes. Advancements in technology such as high-definition imaging, minimal access surgical modalities, and the advent of improved flexible endoscopes with better visualization capabilities are revolutionizing diagnostic and therapeutic aspects. These developments are making the diagnosis or treatment of different medical conditions more accurate and less damaging, which leads to shorter patient recovery times and lower healthcare costs. Moreover, the utilization of artificial intelligence and machine learning in endoscopy improves disease identification accuracy and procedure efficiency. Consequently, the growing acceptance of advanced endoscopy technologies among physicians is propelling endoscopy devices market growth and escalating the demand for ongoing research and development efforts for advanced endoscopy systems.
Rising Prevalence of Gastrointestinal Diseases and Cancer
The increasing prevalence of gastrointestinal diseases and cancer is one of the major factors driving the demand for endoscopy devices. Those with indications for a broad spectrum of endoscopic techniques including colorectal cancer, gastrointestinal hemorrhage, and inflammatory bowel diseases may also be regarded as exemplary clinical populations. In 2020, IARC reported new cases of 19.3 million cancer diagnoses around the globe. GI cancers constituted a great number of the cancers diagnosed, while colorectal cancer alone is responsible for over 935,000 deaths each year. With a survival increase of 40%, early diagnosis by endoscopic techniques has shown improvement in survival from GI cancers. Apart from technological advancements, early diagnosis which is also leading to early treatment of these diseases is crucial for good patient outcomes, thereby aiding the culture of increased endoscopic use. In addition, the increasing aged population, which is more susceptible to these diseases, further drives market growth. Moreover, the increasing emphasis on healthcare and regular monitoring of patients with endoscopes enhances the overall continued demand for endoscopic devices, as they are fundamental in overcoming the rising prevalence of GI and other cancers worldwide.
Expanding Applications of Endoscopy in Various Medical Fields
Applications of endoscopy in diversified medical fields drive the global endoscopy devices market size. In addition to gastroenterology, a wide range of applications within different clinical specialties including urology, gynecology, pulmonology, and orthopedic surgeries in various clinical setups necessitate endoscopy. According to the American Lung Association, bronchoscopy is being increasingly used in the diagnosis of pulmonary conditions including lung cancer that affect 2.2 million individuals each year. These applications are varied and are forcing the development of special endoscopic tools tailored to clinical needs. Along with this, the increasing application of endoscopy for various body system disorders in diagnosis and treatment is also contributing to their demand. Some examples are laparoscopic surgeries in gynecology for endometriosis and minimally invasive urological procedures for kidney stones. This expansion of the utilization of endoscopy strengthens market growth while positively influencing the advancement and development of new types of specialized endoscopic tools for certain branches of medicine.
Endoscopy visualization systems lead the market with around 41.5% of market share in 2025. This can be attributed to their importance in increasing the accuracy and precision of diagnostic and therapeutic procedures. These systems include high-definition cameras, video processors, and display monitors that enhance image quality and resolution which is critical for the accurate identification and subsequent treatment of medical conditions. In particular, the inclusion of 4K and 3D imaging technologies acts as one of the major endoscopy devices market trends that leads to improved visualization systems performance through a more advanced level of detail in internal organs and tissue investigation. In addition, the rising adoption rate of minimally invasive procedures that require excellent visualizing systems for better outcomes will drive the demand for these solutions. Meanwhile, the sustained advances in imaging technology and the higher burden of gastrointestinal diseases and cancer ensure that endoscopy visualization systems will remain a lucrative revenue pocket meeting the changing demands from healthcare providers around the globe for best patient care.
Gastrointestinal endoscopy leads the market with around 55.4% of market share in 2025 due to the escalating number of gastrointestinal diseases and disorders across the globe. This segment includes procedures such as colonoscopy, gastroscopy, and endoscopic retrograde cholangiopancreatography (ERCP) needed for accurate treatment of diseases including colorectal cancer, gastrointestinal bleeding, and inflammatory bowel disease. Along with this, the increasing awareness among patients to undergo diagnosis in the early stage and rising trend of preventive healthcare, are two key drivers facilitating the growth of gastrointestinal endoscopy. These procedures benefit from improved equipment and advanced technologies such as smoother imaging, and enhanced capabilities paired with the convenience of less invasive procedures. The segment is further experiencing market growth as prevalence in the geriatric population with gastrointestinal disorders has been increasing.
Hospitals and clinics lead the market with around 51.0% of market share in 2025. They provide a broad spectrum of diagnostic and therapeutic applications. These endoscopy centers have state-of-the-art endoscopy equipment and resources, so they are capable of delivering a full range of endoscopic procedures needed to diagnose and treat various disorders. Additionally, centers and clinics with specialist medical professionals provide access to research-backed treatments for a fraction of patients. In addition, the large number of patient flow and the urgency of receiving accurate diagnoses on time in these areas present a significant requirement for endoscopy devices. Endoscopy also becomes more enhanced as a whole with high-end technological improvements, helping hospitals and clinics hold the largest endoscopy devices market share. Moreover, the growing burden of chronic diseases and the growing demand for minimally invasive procedures accentuate the adoption of endoscopy devices by hospitals and clinics, solidifying their dominance in the endoscopy devices market.
In 2025, North America accounted for the largest market share of over 38.6%. North America has the highest market share in the market, driven by high per capita income and intense R&D activities that foster innovation for high-quality miniature endoscopes for diagnostic applications. Extra sales growth stems from the region using new diagnostic imaging, high-definition video, and robotics endoscopy technologies first. In addition to this, the rising incidence of lifestyle-related chronic disorders such as cancer and gastrointestinal disorders necessitates more endoscopy procedures. Accessibility to advanced endoscopy equipment opportunities is made easily progressively due to the high presence of top medical device manufacturers and their research and development activities. Along with this, government support and a favorable reimbursement climate are essential facilitators for advanced endoscopic services. Concurrently, the increasing burden of diseases has a positive impact on the endoscopy devices market, along with the growing awareness of early disease detection and preventive healthcare. Moreover, North America leads the way in the adoption of state-of-the-art endoscopy steering healthcare performances and patient outcomes across the globe which is creating a positive endoscopy devices market outlook.
UNITED STATES ENDOSCOPY DEVICES MARKET ANALYSIS
In 2025, the US accounted for around 82.90% of the total North America endoscopy devices market. High expenditure on health, technological progress, and elevated gastrointestinal diseases prevails the U.S. endoscopy devices market. According to the Centers for Medicare & Medicaid Services, expenditures in the health care sector rose to USD 4.5 trillion in 2022 alone. Much funding has been placed for high-quality equipment such as endoscopy devices. Minimally invasive treatments have always gained a position among the world's aging populations. Further technologies such as an AI-powered endoscope are considered more accurate while making a diagnosis. Boston Scientific and Medtronic, for example, are significant players in the market, targeting hospitals and out-of-hospital facilities. The domestic production of devices stabilizes the supply chain and reduces import dependency. Federal initiatives that encourage early disease detection contribute further to demand stimulation. Increasing R&D investments in innovative products help U.S. manufacturers expand their business worldwide, further consolidating their position in the endoscopy devices market.
EUROPE ENDOSCOPY DEVICES MARKET ANALYSIS
The growth of the European endoscopy devices market is driven by rising healthcare investments, a growing incidence of chronic diseases, and early diagnostics. As per the European Commission, in 2022, Germany had allocated EUR 489 billion, which is approximately USD 522 billion, for healthcare purposes, including medical technologies like endoscopy devices. The demand for robotic-assisted endoscopy is rising in countries like the UK and France, driven by technological advancements and the growing preference for minimally invasive solutions. Furthermore, diagnostic endoscopy devices are also expected to be sought out with the increase in colorectal cancer screening programs that are reported by the European Society of Gastrointestinal Endoscopy. Olympus and Karl Storz are among the key players with the most recent technological advancements. Strict EU regulations ensure product quality and safety. Public healthcare systems collaborate with manufacturers to support R&D, thus making Europe the hub for innovation in endoscopy.
ASIA PACIFIC ENDOSCOPY DEVICES MARKET ANALYSIS
Rapidly increasing healthcare spending, awareness of preventive health care, and the growth in the middle class are factors improving the Asia Pacific endoscopy devices market. As per the data provided by China's National Bureau of Statistics, health care expenditure in China stood at USD 1,268.603 billion during 2022, focusing more on advanced diagnostic tools such as endoscopy devices. India's National Health Mission focuses on early disease detection, and in its 2023-2024 budget, the Ministry of Health and Family Welfare has allocated USD 8 billion to healthcare. The outpatient endoscopic procedures in the region are rapidly increasing as these procedures are inexpensive and have very short recovery periods. Innovation in the sector is led by companies such as Fujifilm and Pentax Medical, while the R&D for next-generation endoscopic systems is being supported by initiatives such as Japan's AMED. The partnerships between global and local players enhance technology transfer, making Asia Pacific a key market for endoscopy devices.
LATIN AMERICA ENDOSCOPY DEVICES MARKET ANALYSIS
Growth drivers for Latin America's endoscopy devices market include increasing budgets for healthcare and access to the same, besides a growing number of gastrointestinal diseases. ITA states that in 2022, Brazil spent around USD 161 billion on its healthcare budget. The investments under this budget in diagnostic technologies continue to grow, with public-private partnerships in places including Mexico and Chile working toward improving endoscopic diagnostic capabilities across more rural and less privileged areas. The growing medical tourism in Costa Rica and Colombia enhances the demand for advanced endoscopic devices for minimally invasive procedures. Companies such as Hoya Group are now expanding their operations in the region to cater to this growing demand. Government-sponsored training programs for healthcare professionals help improve the adoption of endoscopic techniques, thus further enhancing the market. Growing healthcare infrastructure in Latin America makes it an emerging player in the global endoscopy devices industry.
MIDDLE EAST AND AFRICA ENDOSCOPY DEVICES MARKET ANALYSIS
Increasing healthcare infrastructure investments along with the escalating prevalence of chronic diseases are currently driving the market for endoscopy devices in the Middle East and Africa. According to International Trade Administration, Saudi Arabia allotted USD 36.8 billion to healthcare during 2022, which targeted the modernization of hospitals as well as the diagnostics sector. In South Africa, there is a developing demand for diagnostic services through less invasive procedures among both public as well as private systems, which tend to prefer advanced endoscopy devices. Regional manufacturers, such as United Surgical, offer competitive, locally sensitive products. Emphasis on developing health care facilities by the government of the UAE under Vision 2030 along with diagnostic technology promotes the acceptance of endoscopic equipment. Awareness among individuals through tie-ups with global players creates more demand. In the Middle East and Africa, the advancement of health care and strategic investment have made the region a great place for endoscopic equipment.
The key players operating in the endoscopy devices market forecast are investing in R&D to find new technologies and update their products. Olympus Corporation, Karl Storz, and Stryker are focusing on these areas, with new imaging technologies, AI & machine learning solutions for better detection, and more flexible or adaptable endoscopes built. In addition, they pursue various primary strategies such as partnerships and global acquisitions to expand their product portfolio on a global level. Moreover, endoscopy devices companies are concentrating on manufacturing minimally invasive surgical tools, as the demand for this surgery is significantly increasing. Sustained training and education programs for healthcare professionals also bolster the utilization of advanced endoscopy devices in clinical applications.